Alcoholic hepatitis medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Alcoholic hepatitis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{CMG}} '''Assosci..." |
|||
| Line 5: | Line 5: | ||
{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]] | {{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]] | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | |||
====Corticosteroids==== | ====Corticosteroids==== | ||
[[Clinical practice guidelines]] by the [[American College of Gastroenterology]] recommend corticosteroids.<ref name="pmid9820369">{{cite journal |author=McCullough AJ, O'Connor JF |title=Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology |journal=Am. J. Gastroenterol. |volume=93 |issue=11 |pages=2022-36 |year=1998 |pmid=9820369 |doi=}}</ref> | [[Clinical practice guidelines]] by the [[American College of Gastroenterology]] recommend corticosteroids.<ref name="pmid9820369">{{cite journal |author=McCullough AJ, O'Connor JF |title=Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology |journal=Am. J. Gastroenterol. |volume=93 |issue=11 |pages=2022-36 |year=1998 |pmid=9820369 |doi=}}</ref> | ||
Revision as of 07:11, 31 August 2012
|
Alcoholic hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alcoholic hepatitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Alcoholic hepatitis medical therapy |
|
Risk calculators and risk factors for Alcoholic hepatitis medical therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S
Overview
Medical Therapy
Corticosteroids
Clinical practice guidelines by the American College of Gastroenterology recommend corticosteroids.[1]
Patients with a discriminant function score > 32 or hepatic encephalopathy should be considered for treatment with prednisolone 40 mg daily for four weeks followed by a taper.[1]
Pentoxifylline
A randomized controlled trial found that 5 patients with a discriminant function score > 32 and at least one of palpable tender hepatomegaly, fever, leukocytosis, hepatic encephalopathy, or hepatic systolic bruit must be treated with pentoxifylline 400 mg orally 3 times daily for 4 weeks for one to prevent one patient from dying. [2]
Acute Pharmacotherapies
- In very severe disease, such as those with encephalopathy or other markers of advanced disease, treatment with steroids may improved outcome – Prednisolone 40 mg every day for 4 weeks and then tapered.
- Possible contraindications to steroids must be considered, such as acute infection, gastrointestinal (GI) hemorrhage, etc.
- Other considerations:
- Acetaminophen use should be < 2gm / day
- Fasting also increases risks of acetaminophen toxicity in alcoholics
- Propylthiouracil (PTU) has been tried in these patients and may be moderately effective in patients who continue the treatment and discontinue alcohol.
- Colchicine 0.6 mg by mouth, twice daily may help to slow progression of liver disease, though the data is not conclusive.
References
- ↑ 1.0 1.1 McCullough AJ, O'Connor JF (1998). "Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology". Am. J. Gastroenterol. 93 (11): 2022–36. PMID 9820369.
- ↑ Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000). "Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial". Gastroenterology. 119 (6): 1637–48. doi:10.1053/gast.2000.20189. PMID 11113085. (ACP Journal Club synopsis)